- (-)

  • -
  • -
  • -
  • -
  • -
Last
- - (-%)
Volume
-
52 Week Range
-
Key Stats
Open -
Day High -
Day Low -
Previous Close -
52 Week High -
52 Week Low -
50 Day Average -
200 Day Average -
Market Cap -
Shares Out -
Book Value -
Ratios/Profitability
EPS -
P/E -
P/B -
Events
Earnings Date -
Latest News
Gilead’s Remdesivir Gets FDA Approval
May 04, 2020

On Friday, President Trump announced that the remdesivir, an antiviral treatment developed by Gilead Sciences, had been authorized by the Food and Drug Administration (FDA) as an emergency treatment f...